Jascayd

Medicinal product

(Invented) name

Jascayd

Active substance (s)

Nerandomilastas

Strength

18 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AA61, nerandomilast

Marketing authorisation holder

Boehringer Ingelheim International GmbH, Vokietija

Date of authorisation

2026-07-15

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Nerandomilastas	18 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121816	107924	1107924	dalomoji lizdinė plokštelė	N10×1		Receptinis	EU/1/26/2040/006	Netiekiama	-	-	No	-	-
121817	107925	1107925	dalomoji lizdinė plokštelė	N30×1		Receptinis	EU/1/26/2040/007	Netiekiama	-	-	No	-	-
121818	107926	1107926	dalomoji lizdinė plokštelė	N60×1		Receptinis	EU/1/26/2040/008	Netiekiama	-	-	No	-	-
121819	107927	1107927	buteliukas	N60		Receptinis	EU/1/26/2040/009	Netiekiama	-	-	No	-	-
121820	107928	1107928	buteliukas	N180		Receptinis	EU/1/26/2040/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-07-15	Registruotas